Literature DB >> 11935286

Vesicle formation and trafficking in endothelial cells and regulation of endothelial barrier function.

Richard D Minshall1, Chinnaswamy Tiruppathi, Stephen M Vogel, Asrar B Malik.   

Abstract

Endothelial barrier function is regulated in part by the transcellular transport of albumin and other macromolecules via endothelial caveolae (i.e., this process is defined as transcytosis). Using pulmonary microvascular endothelial cells, we have identified the specific interactions between a cell surface albumin-docking protein gp60 and caveolin-1 as well as components of the signaling machinery, heterotrimeric G protein (G(i))- and Src-family tyrosine kinase. Ligation of gp60 on the apical membrane induces the release of caveolae from the apical membrane and activation of endocytosis. The formed vesicles contain the gp60-bound albumin and also albumin and other solutes present in the fluid phase. Vesicles are transported in a polarized manner to the basolateral membrane, releasing their contents by exocytosis into the subendothelial space. The signaling functions of G(i) and Src are important in the release of caveolae from the plasma membrane. The Src-induced phosphorylation of caveolin-1 is crucial in regulating interactions of caveolin-1 with other components of the signaling machinery such as G(i), and key signaling entry of caveolae into the cytoplasm and endocytosis of albumin and other solutes. This review addresses the basis of transcytosis in endothelial cells, its central role as a determinant of endothelial barrier function, and signaling mechanisms involved in regulating fission of caveolae and trafficking of the formed vesicles from the luminal to abluminal side of the endothelial barrier.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11935286     DOI: 10.1007/s00418-001-0367-x

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  55 in total

Review 1.  Progress in focus: recent advances in histochemistry and cell biology.

Authors:  Esther Asan
Journal:  Histochem Cell Biol       Date:  2002-11-27       Impact factor: 4.304

Review 2.  Innovative techniques and applications in histochemistry and cell biology.

Authors:  Esther Asan
Journal:  Histochem Cell Biol       Date:  2003-11-28       Impact factor: 4.304

Review 3.  Age-related endothelial dysfunction : potential implications for pharmacotherapy.

Authors:  Rachel L Matz; Ramaroson Andriantsitohaina
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 4.  Action and reaction: the biological response to siRNA and its delivery vehicles.

Authors:  Rosemary L Kanasty; Kathryn A Whitehead; Arturo J Vegas; Daniel G Anderson
Journal:  Mol Ther       Date:  2012-01-17       Impact factor: 11.454

Review 5.  New biotechnological and nanomedicine strategies for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2010 Mar-Apr

6.  Caveolin-1 orchestrates fibroblast growth factor 2 signaling control of angiogenesis in placental artery endothelial cell caveolae.

Authors:  Lin Feng; Wu-Xiang Liao; Quan Luo; Hong-Hai Zhang; Wen Wang; Jing Zheng; Dong-Bao Chen
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

7.  The role of proline in the membrane re-entrant helix of caveolin-1.

Authors:  Satoko Aoki; Annick Thomas; Marc Decaffmeyer; Robert Brasseur; Richard M Epand
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

Review 8.  Targeted endothelial nanomedicine for common acute pathological conditions.

Authors:  Vladimir V Shuvaev; Jacob S Brenner; Vladimir R Muzykantov
Journal:  J Control Release       Date:  2015-10-03       Impact factor: 9.776

9.  Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.

Authors:  Silvia Muro
Journal:  Drug Deliv Transl Res       Date:  2012-06-01       Impact factor: 4.617

10.  Specific binding, uptake, and transport of ICAM-1-targeted nanocarriers across endothelial and subendothelial cell components of the blood-brain barrier.

Authors:  Janet Hsu; Jeff Rappaport; Silvia Muro
Journal:  Pharm Res       Date:  2014-02-21       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.